Dachaigh › Galar Crohn › Texas
Sgrùdaidhean clionaigeach Galar Crohn ann an Texas
Tha 35 sgrùdaidhean airson Galar Crohn a’ lorg phàirtichean aig làraichean ann an Texas.
Bailtean ann an Texas
- Tyler17 sgrùdaidhean
- Houston17 sgrùdaidhean
- San Antonio15 sgrùdaidhean
- Dallas10 sgrùdaidhean
- Lubbock10 sgrùdaidhean
- Lewisville9 sgrùdaidhean
- Round Rock7 sgrùdaidhean
- The Woodlands6 sgrùdaidhean
- Fort Worth6 sgrùdaidhean
- Arlington5 sgrùdaidhean
- Garland4 sgrùdaidhean
- Austin3 sgrùdaidhean
- League City3 sgrùdaidhean
Teacsa sgrùdaidh oifigeil (Beurla)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- agus 10 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07697456Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- agus 2 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- agus 3 a bharrachd
A’ fastadhÌre 3
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Baylor University Medical Center ( Site 5031), Dallas
- Epic Medical Research - Mesquite ( Site 5153), Denton
- Baylor College of Medicine Medical Center ( Site 5020), Houston
- agus 6 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06430801A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- agus 7 a bharrachd
A’ fastadhÌre 4
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gi Alliance - Cedar Park /ID# 268153, Cedar Park
- Houston Methodist Hospital /ID# 265533, Houston
- Caprock Gastro Research - Lubbock /ID# 265541, Lubbock
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06548542A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cook Childrens Medical Center, Fort Worth
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05923073A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Novel Research, LLC, Bellaire
- One of a Kind Clinical research Center TX LLC, Kingwood
- Southern Star Research Institute, LLC, San Antonio
- agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06233461A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- DFW Clinical Trials, Carrollton
- Lubbock Gastroenterology, Lubbock
- Gastroenterology Research of America, LLC, San Antonio
- agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07499232A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
A’ fastadhÌre 3
Aoisean 3 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06663332A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- The University of Texas at Austin, Austin
- DFW Clinical Trials, Carrollton
- Baylor University Medical Center, Dallas
- agus 5 a bharrachd
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07196722Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Inquest Clinical Research-Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center-Site Number: 8400098, Dallas
- Valley Institute of Research-Site Number: 8400004, Harlingen
- agus 8 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- GI Alliance - Lubbock-Site Number: 8400092, Lubbock
- SMS Clinical Research-Site Number: 8400035, Mesquite
- Gastroenterology Research of San Antonio LLC-Site Number: 8400054, San Antonio
- agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184944A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
A’ fastadhÌre 3
Aoisean 2 gu 19 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483099A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- GI Alliance - Cedar Park, Cedar Park
- North Texas Gastroenterology, Denton
- The University of Texas Health Science Center at Houston, Houston
- agus 3 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483073A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Texas Digestive Disease Consultants Cedar Park, Cedar Park
- GI Alliance - Digestive Health Associates of Texas, Dallas
- The University of Texas Health Science Center at Houston, Houston
- agus 7 a bharrachd
A’ fastadhÌre 4
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06045754Standardized Microbiota Transplant Therapy in Crohn's Disease
- UT Southwestern, Dallas
A’ fastadhÌre 2
Aoisean 18 gu 89 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06631586A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT04372108A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Tyler Research Institute, LLC, Tyler
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cook Children's Medical Center, Fort Worth
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05509777Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT05230173HB-adMSCs for the Treatment of Crohn's Disease
- Hope Biosciences Research Foundation, Sugar Land
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07077746A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT06227910A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 22 Cèit 2026 · NCT06764615Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT04751396A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
A’ fastadhÌre 3
Aoisean 2 agus nas sine · Gach gnè · Air ùrachadh 7 Cèit 2026 · NCT05442567A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Texas Children's Hospital, Houston
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Central Texas Clinical Research, LLC, Austin
- Inquest Clinical Research, Baytown
- Novel Research, LLC, Bellaire
- agus 8 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Gibl 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400002, Fredericksburg
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- agus 5 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Houston Methodist Hospital, Houston
A’ fastadhÌre 4
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 15 Faoi 2026 · NCT06257706Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 18 Cèit 2021 · NCT04617184Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.